Cytokinetics Inc
- Stock
- Ticker CYTK
- ISIN US23282W6057
- Nasdaq
Performance, volatility and drawdowns of Cytokinetics Inc since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $45,138. Global equities (VT): $29,042.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −72.4% in 05/2025, measured from the peak in 01/2024. The old peak has not been reached again yet.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 17 | 1.6 | 67 | 1.9 | 18 | 19 | 29 | 48 |
| Operating income | -139 | -156 | -112 | -167 | -178 | -184 | -179 | -167 |
| EBITDA | -137 | -153 | -109 | -164 | -176 | -180 | -176 | -163 |
| Net income | -150 | -161 | -134 | -306 | -183 | -206 | -199 | -190 |
| Earnings per share | -1.26 | -1.36 | -1.12 | -2.55 | -1.50 | -1.67 | -1.50 | -1.37 |
| Balance sheet | ||||||||
| Total assets | 1,402 | 1,264 | 1,226 | 1,437 | 1,425 | 1,273 | 1,925 | 1,825 |
| Liabilities | 1,537 | 1,530 | 1,594 | 1,958 | 2,084 | 2,100 | 2,098 | 2,146 |
| Equity | -135 | -266 | -369 | -521 | -660 | -827 | -173 | -321 |
| Cash | 95 | 74 | 75 | 225 | 123 | 130 | 255 | 203 |
| Long-term debt | 93 | 92 | 159 | 159 | 246 | 247 | 248 | 244 |
| Cash flow | ||||||||
| Operating cash flow | -66 | -132 | -128 | -108 | -143 | -145 | -160 | -124 |
| Capital expenditure | -1.3 | -5.7 | -4.1 | -9.4 | -5.6 | -5.9 | -4.3 | -0.7 |
| Free cash flow | -67 | -137 | -132 | -117 | -148 | -151 | -164 | -125 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2021 at +119.3%, weakest 2024 at −43.7%. 6 of 9 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 4 Nov 2026 | −$1.37 |
| 6 Aug 2026 | −$1.50 |
| 5 May 2026 | −$1.67 |
| 26 Feb 2026 | −$1.50 |
| 5 Nov 2025 | −$2.55 |
| 7 Aug 2025 | −$1.12 |
| 6 May 2025 | −$1.36 |
| 27 Feb 2025 | −$1.26 |
| 7 Nov 2024 | −$1.36 |
| 9 Aug 2024 | −$1.31 |
| 10 May 2024 | −$1.33 |
| 28 Feb 2024 | −$1.38 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €6.4bn
- Market cap in trading currency
- $7.07bn
- Enterprise value
- $6.36bn
- P/E
- –
- P/S
- 62.44
- P/B
- –
- EV/Sales
- 56.16
- EV/EBITDA
- –
- Earnings yield
- –
- FCF yield
- -8.3%
Results (last four quarters)
- Revenue
- $113m
- Gross profit
- –
- EBITDA
- −$695m
- Net income
- −$778m
- Earnings per share
- −$6.04
- Revenue per share
- $0.81
- Revenue growth
- +2,356.5%
- Earnings growth
- –
Profitability
- Gross margin
- –
- Operating margin
- -625.2%
- Net margin
- -686.6%
- Return on equity
- –
- Return on assets
- -42.6%
Balance sheet and cash flow
- Cash
- $1.13bn
- Cash per share
- $8.11
- Financial debt
- $419m
- Debt/equity %
- –
- Current ratio
- 3.36
- Book value per share
- −$2.31
- Operating cash flow
- −$572m
- Free cash flow
- −$589m
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- –
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 139m
- Volume
- 1.42m
- Avg. volume 3 months
- 2.00m
- Relative volume
- 0.7
Price and technicals
- Price
- $50.78
- 1 day
- −1.3%
- 52-week high
- $87.26
- 52-week low
- $50.78
- Distance to 52-week high
- −41.8%
- Distance to 52-week low
- 0.0%
- Distance to 50-day line
- −17.9%
- Distance to 200-day line
- −26.9%
- RSI (14)
- 30
- Volatility 1M
- 59.7%
Performance
- 1 week
- −9.5%
- 1 month
- −18.5%
- 3 months
- −34.1%
- 6 months
- −34.0%
- YTD
- −20.1%
- 1 year
- −21.6%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has CYTK performed since 11/2016?
$10,000 grew to $45,138 by 20 Nov 2026, which is +16.3% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is CYTK?
Volatility was 70.3% per year, measured on monthly returns. The largest decline from a peak was −72.4%, with the low in 05/2025.
How does CYTK compare with a broad equity ETF?
Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, CYTK returned +16.3% at 70.3%. The correlation of monthly returns was 0.20; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.